Terms: = Prostate cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Diagnosis
31 results:
1. First-in-human study of PSMA-targeting agent, [
Zhao R; Ke M; Lv J; Liu S; Liu Y; Zhang J; Xu L; Gu D; Li M; Cai C; Liu Y; Zeng G; Alexoff D; Ploessl K; Zhu L; Kung HF; Wang X
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1753-1762. PubMed ID: 38212531
[TBL] [Abstract] [Full Text] [Related]
2. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetics regulation of prostate cancer: Biomarker and therapeutic potential.
Ragavi R; Muthukumaran P; Nandagopal S; Ahirwar DK; Tomo S; Misra S; Guerriero G; Shukla KK
Urol Oncol; 2023 Aug; 41(8):340-353. PubMed ID: 37032230
[TBL] [Abstract] [Full Text] [Related]
4. Head-to-Head Comparison of 68 Ga-p16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary prostate cancer : A Pilot Study.
Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
[TBL] [Abstract] [Full Text] [Related]
5. New PSMA-Targeting Ligands: Transformation from diagnosis (Ga-68) to Radionuclide Therapy (Lu-177).
Zha Z; Choi SR; Li L; Zhao R; Ploessl K; Yao X; Alexoff D; Zhu L; Kung HF
J Med Chem; 2022 Oct; 65(19):13001-13012. PubMed ID: 36103652
[TBL] [Abstract] [Full Text] [Related]
6. Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and prostate Adenocarcinoma Diagnosed in One Procedure.
Deng F; Kong MX; Lai J
Anticancer Res; 2022 Jul; 42(7):3601-3605. PubMed ID: 35790255
[TBL] [Abstract] [Full Text] [Related]
7. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Features of Muscle-invasive Bladder cancer Arising After prostate Radiotherapy.
Mossanen M; Carvalho FLF; Muralidhar V; Preston MA; Reardon B; Conway JR; Curran C; Freeman D; Sha S; Sonpavde G; Hirsch M; Kibel AS; Van Allen EM; Mouw KW
Eur Urol; 2022 May; 81(5):466-473. PubMed ID: 34953602
[TBL] [Abstract] [Full Text] [Related]
9. Kit-based preparation of [
Hong H; Wang G; Ploessl K; Zha Z; Zang J; Zhu Z; Zhu L; Kung HF
Nucl Med Biol; 2022; 106-107():1-9. PubMed ID: 34952347
[TBL] [Abstract] [Full Text] [Related]
10. Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [
Zha Z; Choi SR; Ploessl K; Alexoff D; Zhao R; Zhu L; Kung HF
Bioconjug Chem; 2021 May; 32(5):1017-1026. PubMed ID: 33872489
[TBL] [Abstract] [Full Text] [Related]
11. Single-Center Analysis of Human Papillomavirus Infection and p16ink4a Expression among Korean Patients with Penile cancer.
Kwon WA; Yoon MY; Kim SH; Seo HK; Chung J; Lee KH; Joung JY; Park WS
Biomed Res Int; 2019; 2019():6940582. PubMed ID: 31032357
[TBL] [Abstract] [Full Text] [Related]
12. Skene's Glands Adenocarcinoma: A Series of 4 Cases.
Tregnago AC; Epstein JI
Am J Surg Pathol; 2018 Nov; 42(11):1513-1521. PubMed ID: 29901570
[TBL] [Abstract] [Full Text] [Related]
13. Next-generation panel sequencing identifies
Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
[TBL] [Abstract] [Full Text] [Related]
14. Association of Common Susceptibility Variants of Pancreatic cancer in Higher-Risk Patients: A PACGENE Study.
Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
[TBL] [Abstract] [Full Text] [Related]
15. miR-24 regulates CDKN1B/p27 expression in prostate cancer.
Lynch SM; McKenna MM; Walsh CP; McKenna DJ
Prostate; 2016 May; 76(7):637-48. PubMed ID: 26847530
[TBL] [Abstract] [Full Text] [Related]
16. p16 Expression in prostate cancer and Nonmalignant Lesions: Novel Findings and Review of the Literature.
Remo A; Pancione M; Zanella C; Manfrin E
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):201-6. PubMed ID: 25906117
[TBL] [Abstract] [Full Text] [Related]
17. [Comparative analysis of gene expression in normal and cancer human prostate cell lines].
Rosenberg IeE; Herashchenko HV; Kashuba VI
Ukr Biochem J; 2014; 86(2):119-28. PubMed ID: 24868918
[TBL] [Abstract] [Full Text] [Related]
18. Incidence and treatment patterns in males presenting with lower urinary tract symptoms to the emergency department in the United States.
Roghmann F; Ghani KR; Kowalczyk KJ; Bhojani N; Sammon JD; Gandaglia G; Trudeau V; Becker A; Sukumar S; Menon M; Zorn KC; Karakiewicz P; Sun M; Noldus J; Trinh QD
J Urol; 2013 Nov; 190(5):1798-804. PubMed ID: 23764070
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic markers of early tumor development.
Dumitrescu RG
Methods Mol Biol; 2012; 863():3-14. PubMed ID: 22359284
[TBL] [Abstract] [Full Text] [Related]
20. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract] [Full Text] [Related]
[Next]
